TD Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-97,470
Closed -$1.91M 1261
2024
Q4
$1.91M Sell
97,470
-42,400
-30% -$840K ﹤0.01% 1024
2024
Q3
$2.53M Buy
139,870
+1,600
+1% +$30.5K ﹤0.01% 959
2024
Q2
$2.4M Buy
138,270
+5,906
+4% +$105K ﹤0.01% 939
2024
Q1
$2.59M Sell
132,364
-87,124
-40% -$1.84M ﹤0.01% 937
2023
Q4
$5.05M Sell
219,488
-22,572
-9% -$505K 0.01% 767
2023
Q3
$5.57M Buy
242,060
+45,246
+23% +$1.15M 0.01% 709
2023
Q2
$5.14M Buy
196,814
+116,572
+145% +$3.08M 0.01% 735
2023
Q1
$2.22M Buy
80,242
+1,600
+2% +$42.2K ﹤0.01% 952
2022
Q4
$1.79M Hold
78,642
﹤0.01% 1022
2022
Q3
$2.69M Sell
78,642
-4,440
-5% -$164K ﹤0.01% 918
2022
Q2
$2.42M Buy
83,082
+34,920
+73% +$888K ﹤0.01% 952
2022
Q1
$1.29M Buy
48,162
+2,680
+6% +$63.3K ﹤0.01% 1190
2021
Q4
$1.18M Buy
45,482
+31,731
+231% +$791K ﹤0.01% 1249
2021
Q3
$324K Sell
13,751
-52,959
-79% -$1.85M ﹤0.01% 1444
2021
Q2
$2.77M Buy
+66,710
New +$2.46M ﹤0.01% 995

Other funds holding PRVA

TD Asset Management's PRVA Position: Q1 2025 in Review

TD Asset Management sold out of Privia Health (PRVA) in Q1 2025, closing a stake of 97,470 shares — an estimated $1.91M sold.

TD Asset Management first reported a position in PRVA in Q2 2021 and held it in 15 quarters. The position peaked at $5.57M in Q3 2023. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

  • TD Asset Management reported no remaining Privia Health position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 97,470 Privia Health shares in Q1 2025, an estimated $1.91M.
  • TD Asset Management first reported a position in Privia Health in Q2 2021 and held it in 15 quarters.
  • TD Asset Management's Privia Health position peaked at $5.57M in Q3 2023.
  • 248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.